Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardion Health Sciences Inc (NASDAQ: GHSI) closed the day trading at $3.23 down -41.70% from the previous closing price of $5.54. In other words, the price has decreased by -$41.70 from its previous closing price. On the day, 0.76 million shares were traded. GHSI stock price reached its highest trading level at $3.57 during the session, while it also had its lowest trading level at $3.04.
Ratios:
For a better understanding of GHSI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.59 and its Current Ratio is at 16.67. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 26 ’24 when Radoff Bradley Louis sold 105,486 shares for $14.10 per share. The transaction valued at 1,487,685 led to the insider holds 112,414 shares of the business.
Radoff Bradley Louis sold 10,054 shares of GHSI for $138,734 on Aug 26 ’24. The 10% Owner now owns 15,046 shares after completing the transaction at $13.80 per share. On Aug 26 ’24, another insider, Radoff Bradley Louis, who serves as the 10% Owner of the company, bought 217,900 shares for $16.49 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GHSI now has a Market Capitalization of 4147836 and an Enterprise Value of -10675002. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 0.30. Its current Enterprise Value per Revenue stands at -0.873 whereas that against EBITDA is 3.002.
Stock Price History:
Over the past 52 weeks, GHSI has reached a high of $9.44, while it has fallen to a 52-week low of $2.63. The 50-Day Moving Average of the stock is -42.62%, while the 200-Day Moving Average is calculated to be -29.25%.
Shares Statistics:
Over the past 3-months, GHSI traded about 181.77K shares per day on average, while over the past 10 days, GHSI traded about 161460 shares per day. A total of 1.28M shares are outstanding, with a floating share count of 1.27M. Insiders hold about 1.36% of the company’s shares, while institutions hold 21.52% stake in the company. Shares short for GHSI as of 1726185600 were 47826 with a Short Ratio of 0.26, compared to 1723680000 on 55590. Therefore, it implies a Short% of Shares Outstanding of 47826 and a Short% of Float of 5.5.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
1 analysts predict $3.21M in revenue for the current quarter. It ranges from a high estimate of $3.21M to a low estimate of $3.21M. As of the current estimate, Guardion Health Sciences Inc’s year-ago sales were $2.79MFor the next quarter, 1 analysts are estimating revenue of $3.5M. There is a high estimate of $3.5M for the next quarter, whereas the lowest estimate is $3.5M.
A total of 1 analysts have provided revenue estimates for GHSI’s current fiscal year. The highest revenue estimate was $13.45M, while the lowest revenue estimate was $13.45M, resulting in an average revenue estimate of $13.45M. In the same quarter a year ago, actual revenue was $12.25MBased on 1 analysts’ estimates, the company’s revenue will be $14.79M in the next fiscal year. The high estimate is $14.79M and the low estimate is $14.79M.
